Both INSYS Therapeutics Inc. (NASDAQ:INSY) and Verona Pharma plc (NASDAQ:VRNA) are Biotechnology companies, competing one another. We will contrast their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership.
Valuation and Earnings
We can see in table 1 the earnings per share, top-line revenue and valuation of INSYS Therapeutics Inc. and Verona Pharma plc.
Table 2 provides us INSYS Therapeutics Inc. and Verona Pharma plc’s return on assets, net margins and return on equity.
The next table highlights the shown recommendations and ratings for INSYS Therapeutics Inc. and Verona Pharma plc.
INSYS Therapeutics Inc. has a consensus target price of $7.75, and a 831.49% upside potential.
Insider Institutional Ownership
The shares of both INSYS Therapeutics Inc. and Verona Pharma plc are owned by institutional investors at 18.9% and 65.7% respectively. Insiders held 63.83%